MedTrace Logo

Adaptive Mixed Reality for Students With Intellectual Disabilities

NCT07647926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-06-15

No results posted yet for this study

Summary

This study design investigates the empirical efficacy of an Adaptive Mixed Reality Learning Environment (AMRLE) tailored for educable adolescents and young adults (aged 10-20) diagnosed with mild-to-moderate intellectual disabilities in Jeddah, Saudi Arabia. Standard digital user interfaces often impose heavy cognitive taxes on neurodivergent learners, generating a operational digital divide that limits their independence. To address this issue, an intelligent application was developed to track behavioral metrics, including response latency and error frequency, dynamically delivery sensory scaffolding, visual pruning, and localized Arabic auditory guidance. The primary purpose is to systematically evaluate the clinical-pedagogical impact of this dynamic spat…

Conditions

  • Intellectual Disability, Mild to Moderate

Interventions

BEHAVIORAL

Adaptive Mixed Reality Learning Environment (AMRLE)

An interactive 3D spatial computing application configured with an adaptivity engine. It continuously processes response latency and error frequencies to deliver visual pruning, multi-sensory concrete-to-abstract micro-scaffolding, and Arabic audio prompts tailored for learning digital autonomy and safety.

Sponsors & Collaborators

  • King Salman Center for Disability Research

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-11
Primary Completion
2026-04-25
Completion
2026-05-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07647926 on ClinicalTrials.gov